News

May 3, 2024

Successful closing of SEK 5 million bridge-round

MedVasc has closed an investment round of 5 M SEK from existing investors. 

The raised capital will be used to initiate manufacturing and final validation of FDA 510k pathway for the company’s anesthesia catheter SolutioTM. SolutioTM improves the golden standard methods for treatment of varicose veins and is expected to reach the American market in 2025.

“We note that in a short time, we managed to attract the funds to reach relevant milestones for the coming development goal for our Solutio ™ catheter, says the company’s CEO, Cathrin Johansson.